{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:59:48Z","timestamp":1785383988635,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,29]]},"DOI":"10.7759\/cureus.113618","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:34:09Z","timestamp":1785382449000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Bullous Pemphigoid: A Case Report"],"prefix":"10.7759","author":[{"given":"Ramachandra Reddy","family":"Gowda Venkatesha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Rajaram Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirnalini","family":"Aravind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasu","family":"Sridharrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandhini","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Bullous Pemphigoid","author":"Baigrie D","year":"2024","unstructured":"Baigrie D, Nookala V. Bullous Pemphigoid. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16970","article-title":"Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis","volume":"63","author":"Jiirasutat N","year":"2024","unstructured":"Jiirasutat N, Pongchareon P, Weschawalit S. Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis. Int J Dermatol. 2024, 63:572-9. 10.1111\/ijd.16970","journal-title":"Int J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5414\/CP204478","article-title":"Gliptin-induced bullous pemphigoid","volume":"62","author":"Ganeva M","year":"2024","unstructured":"Ganeva M, Gancheva T, Manuelyan K, Hristakieva E. Gliptin-induced bullous pemphigoid. Int J Clin Pharmacol Ther. 2024, 62:89-95. 10.5414\/CP204478","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3892\/wasj.2023.185","article-title":"Recurrent bullous pemphigoid: a case report and literature review","volume":"5","author":"Rajaram Mohan K","year":"2023","unstructured":"Rajaram Mohan K, Govindasamy Sugumar SP, Fenn SM, Pethagounder Thangavelu R. Recurrent bullous pemphigoid: a case report and literature review. World Acad Sci J. 2023, 5:1-12. 10.3892\/wasj.2023.185","journal-title":"World Acad Sci J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_68_2024","article-title":"Bullous pemphigoid induced by camrelizumab","author":"Wang Q","year":"2024","unstructured":"Wang Q, Tian R, Zhang D, Nong X. Bullous pemphigoid induced by camrelizumab. Indian J Dermatol Venereol Leprol. 2024, 1-3. 10.25259\/IJDVL_68_2024","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53160","article-title":"Bullous pemphigoid associated with the use of sacubitril\/valsartan: a case report and literature review","volume":"16","author":"Martin Arsanios DA","year":"2024","unstructured":"Martin Arsanios DA, G\u00f3mez-\u00c1lvarez LM, Mu\u00f1oz-Angulo N, Montealegre C, Quintero Mu\u00f1oz E, Calder\u00f3n-Vargas C. Bullous pemphigoid associated with the use of sacubitril\/valsartan: a case report and literature review. Cureus. 2024, 16:e53160. 10.7759\/cureus.53160","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3457","article-title":"A systematic review of drug-induced pemphigoid","volume":"100","author":"Verheyden MJ","year":"2020","unstructured":"Verheyden MJ, Bilgic A, Murrell DF. A systematic review of drug-induced pemphigoid. Acta Derm Venereol. 2020, 100:adv00224. 10.2340\/00015555-3457","journal-title":"Acta Derm Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16940","article-title":"Bullous pemphigoid associated with prodromal-phase by repeated COVID-19 vaccinations","volume":"51","author":"Yamamoto S","year":"2024","unstructured":"Yamamoto S, Koga H, Tsutsumi M, Ishii N, Nakama T. Bullous pemphigoid associated with prodromal-phase by repeated COVID-19 vaccinations. J Dermatol. 2024, 51:e6-7. 10.1111\/1346-8138.16940","journal-title":"J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.09.040","article-title":"Bullous pemphigoid with prominent mucosal involvement in the setting of renal allograft rejection","volume":"44","author":"Hodges WT","year":"2024","unstructured":"Hodges WT, Badawi AH, Rosman IS, Musiek AC, Shmuylovich L. Bullous pemphigoid with prominent mucosal involvement in the setting of renal allograft rejection. JAAD Case Rep. 2024, 44:53-7. 10.1016\/j.jdcr.2023.09.040","journal-title":"JAAD Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61652","article-title":"Perifollicular melanocyte regeneration in bullous pemphigoid","volume":"16","author":"Jhingan I","year":"2024","unstructured":"Jhingan I, Oldham NW, Hyman DA, McBride JD, Levin JI. Perifollicular melanocyte regeneration in bullous pemphigoid. Cureus. 2024, 16:e61652. 10.7759\/cureus.61652","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.15304","article-title":"Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid","volume":"22","author":"Brufau-Cochs M","year":"2024","unstructured":"Brufau-Cochs M, Alamon-Reig F, Luque-Luna M, Bosch-Amate X, Moreta MJ, Bassegoda O, Mascar\u00f3 JM Jr. Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid. J Dtsch Dermatol Ges. 2024, 22:430-2. 10.1111\/ddg.15304","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/01455613241230252","article-title":"Laryngeal manifestations of bullous pemphigoid: case report and review of the literature","author":"Hamdan AL","year":"2024","unstructured":"Hamdan AL, Abou Chaar J, Abou Rahal J. Laryngeal manifestations of bullous pemphigoid: case report and review of the literature. Ear Nose Throat J. 2024, 1455613241230252. 10.1177\/01455613241230252","journal-title":"Ear Nose Throat J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2024.04.013","article-title":"Radiotherapy-induced localized bullous pemphigoid with a favorable response to dupilumab","volume":"48","author":"Wongtada C","year":"2024","unstructured":"Wongtada C, Rerknimitr P. Radiotherapy-induced localized bullous pemphigoid with a favorable response to dupilumab. JAAD Case Rep. 2024, 48:128-30. 10.1016\/j.jdcr.2024.04.013","journal-title":"JAAD Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_353_23","article-title":"Pembrolizumab-induced hypertrophic lichenoid dermatitis and bullous pemphigoid in one patient","volume":"15","author":"Alsabbagh M","year":"2024","unstructured":"Alsabbagh M, Bava A, Ansari S. Pembrolizumab-induced hypertrophic lichenoid dermatitis and bullous pemphigoid in one patient. Indian Dermatol Online J. 2024, 15:546-8. 10.4103\/idoj.IDOJ_353_23","journal-title":"Indian Dermatol Online J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00832-1","article-title":"Advancements in bullous pemphigoid treatment: a comprehensive pipeline update","volume":"25","author":"Karakioulaki M","year":"2024","unstructured":"Karakioulaki M, Eyerich K, Patsatsi A. Advancements in bullous pemphigoid treatment: a comprehensive pipeline update. Am J Clin Dermatol. 2024, 25:195-212. 10.1007\/s40257-023-00832-1","journal-title":"Am J Clin Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad510","article-title":"Omalizumab used to treat bullous pemphigoid resistant to other treatments","volume":"190","year":"2024","unstructured":"Omalizumab used to treat bullous pemphigoid resistant to other treatments. Br J Dermatol. 2024, 190.e23. 10.1093\/bjd\/ljad510","journal-title":"Br J Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19475","article-title":"Abrocitinib-a promising option for patients with refractory bullous pemphigoid","volume":"38","author":"Jiang W","year":"2024","unstructured":"Jiang W, Ma X, Guo T, Song M, Zhang J. Abrocitinib-a promising option for patients with refractory bullous pemphigoid. J Eur Acad Dermatol Venereol. 2024, 38:e119-21. 10.1111\/jdv.19475","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2023.07.017","article-title":"Multirefractory bullous pemphigoid, psoriasis and psoriatic arthritis successfully treated with guselkumab","author":"Rodr\u00edguez-Cuadrado FJ","year":"2024","unstructured":"Rodr\u00edguez-Cuadrado FJ, Roustan-Gull\u00f3n G, Su\u00e1rez-Massa D, Hospital-Gil M. Multirefractory bullous pemphigoid, psoriasis and psoriatic arthritis successfully treated with guselkumab. An Bras Dermatol. 2024, 10.1016\/j.abd.2023.07.017","journal-title":"An Bras Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2024.100282","article-title":"Diacron-reactive oxygen metabolites levels are initially elevated in patients with bullous pemphigoid","volume":"4","author":"Tozaki N","year":"2024","unstructured":"Tozaki N, Tawada C, Tanaka K, et al.. Diacron-reactive oxygen metabolites levels are initially elevated in patients with bullous pemphigoid. JID Innov. 2024, 4:100282. 10.1016\/j.xjidi.2024.100282","journal-title":"JID Innov"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22133","article-title":"Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid","volume":"39","author":"Ahmadpoor P","year":"2024","unstructured":"Ahmadpoor P, Beck M, Michel M, Pambrun E, Stoebner P, Moranne O. Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid. J Clin Apher. 2024, 39:e22133. 10.1002\/jca.22133","journal-title":"J Clin Apher"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278838-recurrent-bullous-pemphigoid-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:34:10Z","timestamp":1785382450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278838-recurrent-bullous-pemphigoid-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.113618","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}